Brief: Aurinia Pharmaceuticals Reports Financial Results For The Three And Nine Months Ended September 30, 2026
30/10/2026 12:31
BRIEF-Aurinia Pharmaceuticals Reports Financial Results For The Three And Nine Months Ended September 30, 2026 Oct 30 (Reuters) - Aurinia Pharmaceuticals Inc. AUPH.O:
AURINIA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND PROVIDES UPDATE ON RECENT BUSINESS PROGRESS
Source text: ID:nBw5th145a
Further company coverage: AUPH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurinia Pharmaceuticals
See all newsAurinia Pharmaceuticals Inc. expected to post earnings of 22 cents a share - Earnings Preview
Brief: Aurinia Pharmaceuticals Reports Financial Results For The Three And Nine Months Ended September 30, 2026
Canada's Aurinia Q3 revenue rises 14% on LUPKYNIS sales
Brief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales